Format conversion
Format Conversion The antibodies obtained through the Antibody Artisan's contract services come with various optional services. If an Fc region is required, we can convert the candidate antibody's Fab into full-length human, human-mouse chimeric, or human-rat chimeric forms, and deliver purified IgG molecules within 10 weeks. After cloning the genes for the VH and VL regions along with the desired constant region into a vector, we simultaneously introduce the light chain and heavy chain vectors into mammalian cells for expression. For more details, please also refer to the selection of antibody formats in the service flow. For pricing, please inquire for confirmation. *This is an optional service for antibodies produced through the Antibody Artisan service. *This menu is not applicable to antibodies you already possess. *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
The listed desired selling price may be revised without prior notice. Additionally, the "desired selling price" is a reference price and not the actual selling price from retailers. The displayed price does not include consumption tax.
Price range
Delivery Time
※As short as 7 weeks from the receipt of the antigen.
Applications/Examples of results
Antibodies produced by "Antibody Craftsman" can be used in various applications just like antibodies produced by conventional methods. Furthermore, since they are Fab antibodies, they possess properties that can provide additional advantages in certain assay systems, such as not needing to remove the Fc region to prevent binding to receptors or to minimize the reaction of human anti-mouse antibodies (HAMA). Additionally, tag-specific detection antibodies are very useful in many applications.
catalog（1）
Download All Catalogs
Company information
Gene Frontier has been expanding its business areas that contribute to the acceleration of biopharmaceuticals, including antibody drugs, and has been advancing the development of its unique technologies. Moving forward, we aim to accelerate our research and development and business development to achieve further growth on a global scale. We will continue to provide unique technologies and services for the development of innovative pharmaceuticals and diagnostic drugs, striving to be a trusted partner for our customers and contribute to 21st-century healthcare.